Table 2.
Group | n | RL | D-d | ChSI | |||||
---|---|---|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | 4 | 5 | ||||
Healthy people, age <55 years old | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Conditionally healthy people, age >65 years old | 18 | 88.9 | 11.1 | 0 | 0 | 0 | 0 | 0 | 0 |
PID | 16 | 75 | 25 | 0 | 0 | 0 | 0 | 0 | 0 |
Chronic phlegmons | 42 | 19 | 78.6 | 2.4 | 0 | 0 | 0 | 9.5 | 7.1 |
Hypertension, PMS | 16 | 93.7 | 6.3 | 0 | 0 | 0 | 0 | 0 | 0 |
Elderly patients (>65 years old) with CHF and encephalopathy | 49 | 53.1 | 36.7 | 10.2 | 0 | 0 | 0 | 32.7 | 2.0 |
Atherosclerotic stenosis of CFA with gangrene | 38 | 5.3 | 31.6 | 52.6 | 10.5 | 0 | 0 | 47.4 | 57.9 |
AIT | 29 | 79.3 | 20.7 | 0 | 0 | 0 | 0 | 0 | 0 |
PsA | 12 | 33.3 | 50 | 16.7 | 0 | 0 | 0 | 8.3 | 8.3 |
Ankylosing spondylitis | 27 | 44.5 | 33.3 | 22.2 | 0 | 0 | 0 | 11.1 | 11.1 |
Valvular heart diseases | 15 | 53.5 | 33.3 | 13.3 | 0 | 0 | 0 | 13.3 | 13.3 |
ReA | 30 | 46.7 | 33.3 | 20 | 0 | 0 | 0 | 23.3 | 20 |
Rheumatoid arthritis | 42 | 31 | 47.6 | 19 | 2.4 | 0 | 0 | 54.8 | 38.5 |
SLE | 49 | 8.2 | 4.1 | 16.3 | 32.6 | 34.7 | 4.1 | 40.8 | 75.5 |
PAPS 1 | 5 | 0 | 0 | 20 | 80 | 0 | 0 | 100 | 100 |
End-stage renal disease (program hemodialysis) 2 | 42 | 4.8 | 16.6 | 54.8 | 21.4 | 2.4 | 0 | 38.1 | 88.1 |
CAD 3 | 23 | 8.7 | 69.6 | 17.4 | 4.3 | 0 | 0 | 21.7 | 43.5 |
Normal function of renal allograft | 24 | 58.3 | 25 | 16.7 | 0 | 0 | 0 | 4.2 | 0 |
Note: PID—Pelvic inflammatory disease; PMS—premenstrual syndrome; CFA—common femoral artery; AIT—autoimmune thyroiditis; PsA—psoriatic arthritis; ReA—reactive arthritis; SLE—systemic lupus erythematosus; PAPS—primary antiphospholipid syndrome; CAD—chronic allograft dysfunction; 1 in women with recurrent miscarriage; 2 initial diseases: chronic glomerulonephritis, diabetes mellitus, and chronic pyelonephritis; 3 there are no correlations between the values of RL and CSI with morphological variants of renal allograft pathology.